Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Executive wellness a legit corporate expense

Executive wellness a legit corporate expense

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

British Journal of Dermatology publishes data on DermTech's new genomic assay for melanoma

British Journal of Dermatology publishes data on DermTech's new genomic assay for melanoma

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

Metamark announces Nature journal published landmark prostate cancer study results

Metamark announces Nature journal published landmark prostate cancer study results

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Trained dog sniffs out colon cancer with 98% accuracy

Trained dog sniffs out colon cancer with 98% accuracy

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

American Cancer Society reports racial disparity continues to increase death rate for some cancers

American Cancer Society reports racial disparity continues to increase death rate for some cancers

Fox Chase announces posting of clinical outcomes data to its website for patient use

Fox Chase announces posting of clinical outcomes data to its website for patient use

New study: FUS protein appears to inhibit growth of prostate cancer cells in lab

New study: FUS protein appears to inhibit growth of prostate cancer cells in lab

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

XYTOS shares cancer patient treatment results

XYTOS shares cancer patient treatment results

Soligenix and CU enter definitive license agreement for novel vaccine thermostabilization technology

Soligenix and CU enter definitive license agreement for novel vaccine thermostabilization technology

Endo and Orion enter oncology R&D collaboration

Endo and Orion enter oncology R&D collaboration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.